Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
Moore JP, Klasse PJ. Moore JP, et al. Among authors: Klasse PJ. J Virol. 2020 Jun 26:JVI.01083-20. doi: 10.1128/JVI.01083-20. Online ahead of print. J Virol. 2020. PMID: 32591466 Free article. Review.
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
Herrera C, Klasse PJ, Michael E, Kake S, Barnes K, Kibler CW, Campbell-Gardener L, Si Z, Sodroski J, Moore JP, Beddows S. Herrera C, et al. Virology. 2005 Jul 20;338(1):154-72. doi: 10.1016/j.virol.2005.05.002. Virology. 2005. PMID: 15932765
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
Beddows S, Franti M, Dey AK, Kirschner M, Iyer SP, Fisch DC, Ketas T, Yuste E, Desrosiers RC, Klasse PJ, Maddon PJ, Olson WC, Moore JP. Beddows S, et al. Virology. 2007 Apr 10;360(2):329-40. doi: 10.1016/j.virol.2006.10.032. Epub 2006 Nov 28. Virology. 2007. PMID: 17126869
157 results
Jump to page